BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,080 filers reported holding BAXTER INTL INC in Q3 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,557 | -17.7% | 491,688 | -0.6% | 0.06% | -18.6% |
| Q2 2023 | $22,544 | +19.7% | 494,816 | +6.6% | 0.07% | +7.7% |
| Q1 2023 | $18,828 | +73.0% | 464,193 | +117.4% | 0.06% | +58.5% |
| Q4 2022 | $10,881 | -99.8% | 213,490 | +130.8% | 0.04% | +95.2% |
| Q3 2022 | $4,982,000 | +83.4% | 92,504 | +118.7% | 0.02% | +75.0% |
| Q2 2022 | $2,717,000 | -33.2% | 42,305 | -19.3% | 0.01% | -25.0% |
| Q1 2022 | $4,066,000 | -15.4% | 52,433 | -6.4% | 0.02% | -11.1% |
| Q4 2021 | $4,808,000 | +38.2% | 56,016 | +29.5% | 0.02% | +28.6% |
| Q3 2021 | $3,478,000 | -8.5% | 43,243 | -8.4% | 0.01% | -22.2% |
| Q2 2021 | $3,802,000 | +5.1% | 47,234 | +10.2% | 0.02% | -5.3% |
| Q1 2021 | $3,616,000 | -13.6% | 42,874 | -17.8% | 0.02% | -20.8% |
| Q4 2020 | $4,185,000 | -2.6% | 52,156 | -2.4% | 0.02% | -11.1% |
| Q3 2020 | $4,297,000 | -15.3% | 53,436 | -9.3% | 0.03% | -20.6% |
| Q2 2020 | $5,071,000 | -7.8% | 58,891 | -13.1% | 0.03% | -24.4% |
| Q1 2020 | $5,500,000 | +12.7% | 67,738 | +16.1% | 0.04% | +32.4% |
| Q4 2019 | $4,879,000 | +9.9% | 58,353 | +14.9% | 0.03% | -2.9% |
| Q3 2019 | $4,441,000 | +3.5% | 50,771 | -3.1% | 0.04% | 0.0% |
| Q2 2019 | $4,292,000 | -15.6% | 52,411 | -16.2% | 0.04% | -22.2% |
| Q1 2019 | $5,086,000 | -67.1% | 62,554 | -73.4% | 0.04% | -40.8% |
| Q4 2018 | $15,472,000 | +61.6% | 235,116 | +89.3% | 0.08% | -9.5% |
| Q3 2018 | $9,573,000 | -47.7% | 124,187 | -49.9% | 0.08% | -3.4% |
| Q2 2018 | $18,296,000 | +125.9% | 247,796 | +99.0% | 0.09% | +8.8% |
| Q1 2018 | $8,099,000 | -13.4% | 124,530 | -14.0% | 0.08% | -15.8% |
| Q4 2017 | $9,355,000 | -1.8% | 144,729 | -4.7% | 0.10% | -5.9% |
| Q3 2017 | $9,525,000 | -4.5% | 151,822 | -7.9% | 0.10% | -6.5% |
| Q2 2017 | $9,976,000 | -2.6% | 164,771 | -16.6% | 0.11% | -4.4% |
| Q1 2017 | $10,240,000 | +11.9% | 197,457 | -4.3% | 0.11% | +2.7% |
| Q4 2016 | $9,147,000 | +7.6% | 206,292 | +15.5% | 0.11% | 0.0% |
| Q3 2016 | $8,501,000 | +5.2% | 178,595 | -0.0% | 0.11% | -1.8% |
| Q2 2016 | $8,077,000 | +67.8% | 178,606 | +52.5% | 0.11% | +55.6% |
| Q1 2016 | $4,813,000 | +151.9% | 117,148 | +133.8% | 0.07% | +132.3% |
| Q4 2015 | $1,911,000 | +226.1% | 50,103 | +181.0% | 0.03% | +210.0% |
| Q3 2015 | $586,000 | -37.2% | 17,832 | -27.4% | 0.01% | -37.5% |
| Q2 2015 | $933,000 | -65.6% | 24,548 | -37.9% | 0.02% | -66.7% |
| Q1 2015 | $2,709,000 | -25.2% | 39,552 | -19.9% | 0.05% | -29.4% |
| Q4 2014 | $3,622,000 | +33.7% | 49,409 | +30.8% | 0.07% | +25.9% |
| Q3 2014 | $2,710,000 | +6.4% | 37,761 | +7.2% | 0.05% | +50.0% |
| Q2 2014 | $2,546,000 | +30.4% | 35,213 | +32.7% | 0.04% | +20.0% |
| Q1 2014 | $1,952,000 | +60.4% | 26,534 | +51.6% | 0.03% | +50.0% |
| Q4 2013 | $1,217,000 | -57.4% | 17,500 | -59.8% | 0.02% | -62.3% |
| Q3 2013 | $2,859,000 | +12.9% | 43,525 | +19.0% | 0.05% | +6.0% |
| Q2 2013 | $2,533,000 | – | 36,565 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |